Xbrane Reveals Ranibizumab Refiling Plans For US

FDA Said Additional Information Was Needed To Accept Lucentis Rival BLA For Review

 
• By David Wallace
More Info Button
More information on the filing was requested by the FDA • Source: Shutterstock

More from Biosimilars

More from Products